Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Vogel

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Scientific Reports|April 8, 2021
Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockadeKim M Kraus, Julius C Fischer, Kai J Borm, et al.
Aktuelle Urologie|April 9, 2020
[Stereotactic body radiotherapy (SBRT) for the treatment of bone metastases in oligometastasised prostate cancer]Eva Katharina Sage, Marco M E Vogel, Sabrina Dewes, et al.
Radiation Oncology (London, England)|November 13, 2019
Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomyMarco M E Vogel, Kerstin A Kessel, Kilian Schiller, et al.
Frontiers in Oncology|August 16, 2021
Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy <i>Versus</i> Conventional Salvage Radiotherapy for Patients With Recurrent Prostate CancerMarco M E Vogel, Sabrina Dewes, Eva K Sage, et al.
Scientific Reports|January 17, 2025
Biochemical failure-free survival of <sup>18</sup>F-rhPSMA-7 and <sup>18</sup>F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancerMarco M E Vogel, Isabel Rauscher, Jürgen E Gschwend, et al.
European Urology Oncology|October 24, 2022
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guidelineMarco M E Vogel, Mathias Düsberg, Lucia Stöhrer, et al.
European Urology Oncology|May 27, 2020
PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation TherapyKilian Schiller, Lucia Stöhrer, Mathias Düsberg, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 5, 2023
Radiotherapy concepts for spinal metastases-results from an online survey among radiation oncologists of the German Society for Radiation OncologyMaria Waltenberger, Marco M E Vogel, Denise Bernhardt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2023
Mobile applications in radiation oncology-current choices and future potentialsStefan Janssen, Rami A El Shafie, Arne M Ruder, et al.
Clinical and Translational Radiation Oncology|October 23, 2018
Cancer clinical trials - Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC)Kerstin A Kessel, Marco M E Vogel, Carmen Kessel, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Scientific Reports|April 8, 2021
Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockadeKim M Kraus, Julius C Fischer, Kai J Borm, et al.
Aktuelle Urologie|April 9, 2020
[Stereotactic body radiotherapy (SBRT) for the treatment of bone metastases in oligometastasised prostate cancer]Eva Katharina Sage, Marco M E Vogel, Sabrina Dewes, et al.
Radiation Oncology (London, England)|November 13, 2019
Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomyMarco M E Vogel, Kerstin A Kessel, Kilian Schiller, et al.
Frontiers in Oncology|August 16, 2021
Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy <i>Versus</i> Conventional Salvage Radiotherapy for Patients With Recurrent Prostate CancerMarco M E Vogel, Sabrina Dewes, Eva K Sage, et al.
Scientific Reports|January 17, 2025
Biochemical failure-free survival of <sup>18</sup>F-rhPSMA-7 and <sup>18</sup>F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancerMarco M E Vogel, Isabel Rauscher, Jürgen E Gschwend, et al.
European Urology Oncology|October 24, 2022
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guidelineMarco M E Vogel, Mathias Düsberg, Lucia Stöhrer, et al.
European Urology Oncology|May 27, 2020
PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation TherapyKilian Schiller, Lucia Stöhrer, Mathias Düsberg, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 5, 2023
Radiotherapy concepts for spinal metastases-results from an online survey among radiation oncologists of the German Society for Radiation OncologyMaria Waltenberger, Marco M E Vogel, Denise Bernhardt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2023
Mobile applications in radiation oncology-current choices and future potentialsStefan Janssen, Rami A El Shafie, Arne M Ruder, et al.
Clinical and Translational Radiation Oncology|October 23, 2018
Cancer clinical trials - Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC)Kerstin A Kessel, Marco M E Vogel, Carmen Kessel, et al.
Pageof 5